October 18, 2019

October 17, 2019

Subscribe to Latest Legal News and Analysis

October 16, 2019

Subscribe to Latest Legal News and Analysis

October 15, 2019

Subscribe to Latest Legal News and Analysis

USDA Seeks Stakeholder Input to Support Forthcoming Proposed GM Labeling Rule

As the food industry is well aware, legislation requiring labeling of genetically modified (GM) foods was signed into law on July 29, 2016. The National Bioengineered Food Disclosure Law directs the U.S. Department of Agriculture (USDA) to develop regulations and standards to create mandatory disclosure requirements for bio-engineered foods by July 2018. Under the new law, food companies would have three options to disclose GM ingredients: the use of on-package text, a USDA-created symbol, or an internet link - i.e., a QR code printed on the package that directs customers to GM information. 

On June 28, 2017, USDA's Agricultural Marketing Service (AMS) posted a list of 30 questions to obtain stakeholder input to facilitate the drafting of mandatory disclosure requirements. The questions - which are certain to generate significant comments from industry and consumer advocates alike - can generally be divided into five broad categories: (1) Terminology, (2) Definitions, (3) Disclosures, (4) Exemptions, and (5) Compliance. Notable questions follow below.

Terminology

  • What terms AMS should consider interchangeable with bioengineering, and what amount of a bioengineered substance present in a food should make it be considered bioengineered?

  • What breeding techniques should AMS consider to meet the definition of "conventional breeding"?

Definitions

  • Should a bioengineered food include highly refined products such as oils or sugars derived from crops, or what amount of a bioengineered substance would make a food be deemed "bioengineered"?

  • How should AMS define "very small" or "small packages" for purposes of special provisions on disclosure?

  • How should AMS define which retail food establishments are "similar" to restaurants; and what types of records should be required for compliance purposes?

Disclosures

  • What is the amount of a bioengineered substance present in a food that should make it be considered bioengineered and hence subject to disclosure?

  • How should disclosures be made for bulk, vending machine, and online purchases?

  • If a manufacturer chooses to use text or a symbol to disclose a bioengineered food, what text or symbol should AMS require for the disclosure?

Exemptions

  • What types of modifications should be exempt from disclosure?

  • How should AMS craft language in the rule acknowledging that animals consuming bioengineered feed are exempt from the disclosure requirements as bioengineered solely because they fed on bioengineered feed?

Compliance

  • What types of records would establish regulatory compliance with the forthcoming bioengineered food disclosure rule?

  • What are appropriate adjudication procedures for audits and compliance actions?

In general, many of the questions are open-ended and effectively provides industry with the opportunity to shape the forthcoming proposed rule on the federal bioengineered food disclosure requirements. As USDA begins accepting stakeholder feedback on these questions, the Agency is concurrently completing a study examining the challenges of GM disclosure through a smartphone-scannable digital code for both consumers and retailers which could potentially reignite controversy regarding the best way to inform consumers about GM ingredients.

Looking ahead, USDA officials remain optimistic that the Agency continues to be on track to meet the July 2018 deadline to publish a final rule as mandated under the National Bioengineered Food Disclosure Law. Presumably, the current request for stakeholder feedback is part of the Agency's efforts to meet this deadline by soliciting feedback on the issues they anticipate will be the most contentious in the course of the formal rulemaking process.

An exceedingly short time frame - roughly three weeks - has been provided for stakeholders to submit comments to USDA's 30 questions. Responses to the questions should be submitted to GMOlabeling@ams.usda.gov by July 17, 2017.

© 2019 Keller and Heckman LLP

TRENDING LEGAL ANALYSIS


About this Author

Melvin S. Drozen, FDA, regulatory lawyer, Keller Heckman, law firm
Partner

Melvin S. Drozen joined Keller and Heckman in 1987.

Mr. Drozen advises clients on a broad spectrum of FDA, FTC, USDA and EPA (pesticides) regulatory matters, ranging from premarket approval requirements for food additives, dietary supplement ingredients, drugs, and medical devices to advertising and labeling provisions applicable to all of these products. Prior to joining Keller and Heckman, he was an Assistant District Attorney in Brooklyn, N.Y., and then an attorney in the General Counsel's Office of the Food and Drug Administration for seven...

202-434-4222
 Leslie T. Krasny, Keller Heckman, Administrative Law Matters lawyer, Food Supplement Regulation Attorney
Senior Counsel

Leslie Krasny joined Keller and Heckman in June 2001 and was instrumental in opening Keller and Heckman's San Francisco office. Ms. Krasny practices in the areas of regulatory and administrative law, primarily focusing on food/dietary supplement and consumer product industry matters, including safety and labeling, recalls, ingredient evaluations/GRAS opinions, health-related claim substantiation, organic requirements, green/sustainability claims, advertising, California's Proposition 65, recall insurance policies, continuing product guarantees, international trade and biotechnology.

She represents major food companies, from growers and manufacturers to retailers, and serves as General Counsel to the Produce Marketing Association. Ms. Krasny was Vice President and General Counsel of Dole Packaged Foods Company and also specialized in food and drug law in private practice prior to joining Keller and Heckman, San Francisco. She is a member of the Board of Directors of the Food and Drug Law Institute, serves on its Foods and Dietary Supplements Committee, and is on the Editorial Advisory Board of Food Processing Magazine. Ms. Krasny is a frequent speaker on food law at conferences and webinars. 

415-948-2810
Evangelia C. Pelonis, food and drug regulatory lawyer, Keller Heckman law firm
Partner

Evangelia C. Pelonis joined Keller and Heckman in 2003 as a Food and Drug Associate. Ms. Pelonis' practice focuses on all regulatory and compliance matters of the U.S. Food and Drug Administration and the U.S. Department of Agriculture relating to human food, animal feed, food additives and ingredients, and dietary supplements. Ms. Pelonis' works with clients to achieve their marketing goals within the applicable legal frameworks. She counsels clients in all aspects of food development and marketing, from product formulation and manufacturing considerations to food...

202-434-4106
Natalie E. Rainer, Keller Heckman, US Regulatory Compliance Attorney, Environmental Torts Lawyer,
Associate

Natalie Rainer joined Keller and Heckman in 2007. She practices in the area of food and drug law.

Ms. Rainer advises corporate clients regarding regulatory compliance in North America, Latin America, Europe, and Asia. During graduate school, Ms. Rainer worked at the U.S. Department of Justice, Civil Division as an intern in the Environmental Torts Section. In this position she participated in the defense of the federal government in multi-million dollar environmental lawsuits and wrote a successful U.S. Court of Appeals brief defending the...

415-948-2821